Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Opis bibliograficzny
1. autor:	Monayem, Kazi Fahim
Kolejni autorzy:	Momtaz, Tanisha
Format:	Praca dyplomowa
Język:	English
Wydane:	Brac University 2024
Hasła przedmiotowe:	Hepatocellular carcinoma Lenvatinib Sorafenib Demographic analysis Clinical decision making Randomized controlled trials Progression-free survival Liver > Cancer > Treatment. Cancer > Molecular aspects.
Dostęp online:	http://hdl.handle.net/10361/23930

Podobne zapisy

Elucidating the functional roles of bidirectionally transcribed genes in immunobiology of cancers
od: Ahmad, Sheikh Shafin
Wydane: (2021)

Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: a systematic review and meta-analysis
od: Shawn, Ibna Hasan
Wydane: (2024)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
od: Shobnam, Sohana
Wydane: (2024)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
od: Paul, Pulock
Wydane: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
od: Hasan, Amit
Wydane: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
od: Hoque, Ismoth Ara
Wydane: (2024)

Arresting tumor cell proliferation and inhibition of AKT pathway via the use of multikinase inhibitor sorafenib forthe treatment of glioblastoma
od: Raju, Md. Ismail
Wydane: (2022)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
od: Rahman, Tasnim
Wydane: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
od: Hasan, Sakib
Wydane: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
od: Mirza, Maisa Tasnim
Wydane: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Karim, Samia Binte
Wydane: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
od: Bristy, Israt Zerin
Wydane: (2021)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
od: Oishy, Jannatun Noor
Wydane: (2024)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
od: Rahman, Sanjida
Wydane: (2024)

Anticancer activity of alangium salvifolium flower in ehrlich ascites carcinoma bearing mice
od: Zahan, Ronok, i wsp.
Wydane: (2016)

Exploring the use of Ingenol Mebutate to prevent non-melanoma skin cancer: A review
od: Haque, Fariha
Wydane: (2023)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
od: Abir, Shifaty Nur
Wydane: (2024)

In vitro antioxidant and anti-neoplastic activities of Ocimum sanctum leaves in Ehrlich Ascites Carcinoma bearing mice
od: Islam, M. Saiful, i wsp.
Wydane: (2016)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
od: Hossain, Safa Binte
Wydane: (2019)

Hypothesizing precise cancer treatments based on patient survival using machine learning & deep learning
od: Sakib, Hasibul, i wsp.
Wydane: (2024)

Statistics and informatics in molecular cancer research

Immunotherapy in the treatment of renal cancer
od: Shimu, Sumaya
Wydane: (2022)

Effect of passive immunization with mouse Anti-BCG 64 kDa protein on ehrlich ascites carcinoma cells
od: Chowdhury, Maisha Mosharrat
Wydane: (2018)

Multidisciplinary Treatment of Hepatocellular Carcinoma
Wydane: (2013)

Diagnosis and treatment of non-alcoholic fatty liver disease
od: Haque, Sanjida
Wydane: (2020)

Cancer risk factors: a critical review
od: Tabassum, Tahsina
Wydane: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
od: Nawar, Anika
Wydane: (2019)

A systematic review on the comparison of the safety and efficacy of temozolomide and radiotherapy along with another drug combination in the treatment of glioblastoma multiforme
od: Chowdhury, Shamima Zerin
Wydane: (2022)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
od: Zangmo, Thinley
Wydane: (2024)

Targeting BRAFV600E in the treatment of CRC
od: Roja, Mashwiyat Samrin
Wydane: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Wydane: (2024)

Role of statins as antagonists of SPARC in gastric cancer
od: Shahmat, Rad
Wydane: (2019)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
od: Pial, Sazia Afrin
Wydane: (2018)

A systematic review on the efficacy of Fluoxetine in the management of anxiety disorders
od: Akter, Rabia
Wydane: (2024)

Changing global policy to deliver safe, equitable, and affordable care for women's cancers
od: Ginsburg, Ophira M., i wsp.
Wydane: (2018)

Epigenetic therapy in cancer
od: Abid, Md. Shadman Ridwan
Wydane: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
od: Khondokar, Faiza
Wydane: (2022)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
od: Mukti, Roushney Fatima, i wsp.
Wydane: (2016)

RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Wydane: (2024)

Biosimilar in lymphoma treatment
od: Tanisha, Mehrin Haque
Wydane: (2021)